Silexion Therapeutics Corp Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Silexion Therapeutics Corp quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2023 to Q3 2024.
  • Silexion Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $2.92M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.92M +$2.92M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $522K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.